Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poupak Fallahi

Showing results (141-150 of 270) with videos related to

Pageof 27
Sort By:
Metabolism: Clinical and Experimental|December 17, 2009
Prevalence of thyroid dysfunctions in systemic lupus erythematosusAlessandro Antonelli, Poupak Fallahi, Marta Mosca, et al.
Cytokine|February 20, 2008
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditisAlessandro Antonelli, Clodoveo Ferri, Poupak Fallahi, et al.
Expert Review of Anticancer Therapy|July 9, 2015
Sorafenib in the treatment of thyroid cancerSilvia Martina Ferrari, Ugo Politti, Roberto Spisni, et al.
Scientific Reports|December 23, 2025
Antiproliferative activity of Moringa oleifera (L.) Lam. and Moringa stenopetala (Bak.) Cufod. leaves extract against selected cancer cells in primary cell cultureMasresha Ahmed Assaye, Poupak Fallahi, Duccio Volterrani, et al.
Clinical Endocrinology|January 16, 2008
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity testsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2008
Dedifferentiated thyroid cancer: a therapeutic challengeAlessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
Endocrine|August 20, 2015
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutationPoupak Fallahi, Silvia Martina Ferrari, Concettina La Motta, et al.
International Journal of Molecular Sciences|March 20, 2015
New therapies for dedifferentiated papillary thyroid cancerPoupak Fallahi, Valeria Mazzi, Roberto Vita, et al.
Autoimmunity Reviews|May 7, 2019
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathySilvia Martina Ferrari, Francesca Ragusa, Sabrina Rosaria Paparo, et al.
Cancer Cytopathology|January 11, 2016
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysisNicla Borrelli, Clara Ugolini, Riccardo Giannini, et al.
Pageof 27

Showing results (141-150 of 270) with videos related to

Sort By:
Pageof 27
Metabolism: Clinical and Experimental|December 17, 2009
Prevalence of thyroid dysfunctions in systemic lupus erythematosusAlessandro Antonelli, Poupak Fallahi, Marta Mosca, et al.
Cytokine|February 20, 2008
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditisAlessandro Antonelli, Clodoveo Ferri, Poupak Fallahi, et al.
Expert Review of Anticancer Therapy|July 9, 2015
Sorafenib in the treatment of thyroid cancerSilvia Martina Ferrari, Ugo Politti, Roberto Spisni, et al.
Scientific Reports|December 23, 2025
Antiproliferative activity of Moringa oleifera (L.) Lam. and Moringa stenopetala (Bak.) Cufod. leaves extract against selected cancer cells in primary cell cultureMasresha Ahmed Assaye, Poupak Fallahi, Duccio Volterrani, et al.
Clinical Endocrinology|January 16, 2008
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity testsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2008
Dedifferentiated thyroid cancer: a therapeutic challengeAlessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
Endocrine|August 20, 2015
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutationPoupak Fallahi, Silvia Martina Ferrari, Concettina La Motta, et al.
International Journal of Molecular Sciences|March 20, 2015
New therapies for dedifferentiated papillary thyroid cancerPoupak Fallahi, Valeria Mazzi, Roberto Vita, et al.
Autoimmunity Reviews|May 7, 2019
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathySilvia Martina Ferrari, Francesca Ragusa, Sabrina Rosaria Paparo, et al.
Cancer Cytopathology|January 11, 2016
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysisNicla Borrelli, Clara Ugolini, Riccardo Giannini, et al.
Pageof 27